To Understand characteristics of Patients with Anaemia in Chronic Kidney Disease receiving Darboti
Phase 4
- Conditions
- Health Condition 1: R790- Abnormal level of blood mineralHealth Condition 2: D631- Anemia in chronic kidney disease
- Registration Number
- CTRI/2021/07/035250
- Lead Sponsor
- Wockhardt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult patients (of age 18-80 years) with Anaemia in CKD prescribed with Darbotinââ??¢
2.Patient willing to comply with the study protocol and written informed consent.
Exclusion Criteria
Patient not willing to comply with the study protocol and written informed consent.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method